Aemetis price target raised to $20 from $19 at Ascendiant

Ascendiant analyst Edward Woo raised the firm’s price target on Aemetis (AMTX) to $20 from $19 and keeps a Buy rating on the shares. The company reported weaker Q1 revenue but a positive outlook for 2025, the analyst tells investors in a research note. The firm says Aemetis’ large product potential for renewable fuels makes the stock attractive.